Jyong Biotech Ltd Ordinary Shares (MENS) has had the highest return since August 1, 2025 by a small-cap US stock, returning 137.8%.
Jyong Biotech Ltd Ordinary Shares (MENS) has had the highest return since August 1, 2025 by a small-cap US stock, returning 137.8%.
| ASSET | % RETURN |
|---|---|
| Jyong Biotech Ltd Ordinary Shares (MENS) | 137.83% |
| Zepp Health (ZEPP) | 95.67% |
| Y mAbs Therapeutics (YMAB) | 93.41% |
| GCM Grosvenor (GCMGW) | 86.55% |
| NioCorp Developments Ltd Common Stock (NB) | 74.26% |
| Ondas (ONDS) | 73.17% |
| Myriad Genetics (MYGN) | 68.09% |
| Skywater Technology (SKYT) | 60.91% |
| Aveanna Healthcare (AVAH) | 57.84% |
| Steelcase (SCS) | 55.53% |
| Rigel Pharmaceuticals (RIGL) | 53.51% |
| Holley (HLLY) | 53.17% |
| STAAR Surgical (STAA) | 53.15% |
| Emergent Biosolutions (EBS) | 51.15% |
| Katapult Holdings Equity Warrants Exp 09 June 2026 (KPLTW) | 49.35% |
| Mativ (MATV) | 46.49% |
| Backblaze (BLZE) | 45.21% |
| Idaho Strategic Resources (IDR) | 44.97% |
| Newegg Commerce (NEGG) | 42.74% |
| Claritev (CTEV) | 42.49% |
| Advantage Solutions (ADV) | 39.39% |
| OPTIMIZERx (OPRX) | 38.96% |
| Grocery Outlet (GO) | 37.95% |
| SIGA Technologies (SIGA) | 37.42% |
| Willdan (WLDN) | 36.66% |
Small-cap stocks are treated as having a market cap between $300M and $2B.